Viral forensic genomics reveals the relatedness of classic herpes simplex virus strains KOS, KOS63, and KOS79

Virology

Volumn 492, Issue , 2016, Pages 179-186

  Bowen, Christopher D ^a   Renner, Daniel W ^a   Shreve, Jacob T ^a   Tafuri, Yolanda ^b   Payne, Kimberly M ^c   Dix, Richard D ^d,e   Kinchington, Paul R ^c   Gatherer, Derek ^f   Szpara, Moriah L ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d GEORGIA STATE UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Co infection; Genetic distance; Genome; HSV 1; KOS; KOS63; KOS79; Variation

Indexed keywords

ARTICLE; ASIA; EUROPE; FETUS; GENE SEQUENCE; GENETIC DISTANCE; GEOGRAPHIC ORIGIN; HERPES SIMPLEX VIRUS 1 (STRAIN KOS); HERPES SIMPLEX VIRUS 1 (STRAIN KOS63); HERPES SIMPLEX VIRUS 1 (STRAIN KOS79); HUMAN; HUMAN CELL; MOLECULAR PHYLOGENY; NONHUMAN; NORTH AMERICA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS GENOME; VIRUS STRAIN; ADULT; CELL LINE; CLASSIFICATION; FIBROBLAST; FORENSIC GENETICS; GENETIC VARIATION; GENETICS; HERPES SIMPLEX; HIGH THROUGHPUT SEQUENCING; HUMAN ALPHAHERPESVIRUS 1; ISOLATION AND PURIFICATION; PHYLOGENY; PHYLOGEOGRAPHY; VIROLOGY;

VIRUS DNA;

ADULT; ASIA; CELL LINE; DNA, VIRAL; EUROPE; FETUS; FIBROBLASTS; FORENSIC GENETICS; GENETIC VARIATION; GENOME, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NORTH AMERICA; PHYLOGENY; PHYLOGEOGRAPHY;

EID: 84959449997     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2016.02.013     Document Type: Article

References (76)

1. Brandt C.R., Kolb A.W., Shah D.D., Pumfery A.M., Kintner R.L., Jaehnig E., Van Gompel J.J. Multiple determinants contribute to the virulence of HSV ocular and CNS infection and identification of serine 34 of the US1 gene as an ocular disease determinant. Invest. Ophthalmol. Vis. Sci. 2003, 44:2657-2668.
2. Buchman T.G., Simpson T., Nosal C., Roizman B. The structure of herpes simplex virus DNA and its application to molecular epidemiology. Ann. NY Acad. Sci. 1980, 354:279-290.
3. Bowden R., Sakaoka H., Donnelly P., Ward R. High recombination rate in herpes simplex virus type 1 natural populations suggests significant co-infection. Infect. Genet. Evol. 2004, 4:115-123.
4. Corey L., Spear P.G. Infections with herpes simplex viruses. N. Engl. J. Med. 1986, 314:686-691.
5. Croen K.D., Ostrove J.M., Dragovic L.J., Smialek J.E., Straus S.E. Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization. N. Engl. J. Med. 1987, 317:1427-1432.
6. Coen D.M., Whitley R.J. Antiviral drugs and antiviral drug resistance. Curr. Opin. Virol. 2011, 1:545-547.
7. Colgrove R.C., Liu X., Griffiths A., Raja P., Deluca N.A., Newman R.M., Coen D.M., Knipe D.M. History and genomic sequence analysis of the herpes simplex virus 1 KOS and KOS1.1 sub-strains. Virology 2016, 487:215-221.
8. Cha T., Tom E., Kemble G.W., Duke G.M., Mocarski E.S., Spaete R.R. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 1996, 70:78-83.
9. Dix R.D., McKendall R.R., Baringer J.R. Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect. Immun. 1983, 40:103-112.
10. Draper J.M., Huang G., Stephenson G.S., Bertke A.S., Cortez D.a, LaVail J.H. Delivery of herpes simplex virus to retinal ganglion cell axon is dependent on viral protein Us9. Invest. Ophthalmol. Vis. Sci. 2013, 54:962-967.
11. Davison A.J. Evolution of sexually transmitted and sexually transmissible human herpesviruses. Ann. NY Acad. Sci. 2012, 1230:E37-E49.
12. Ejercito P.M., Kieff E.D., Roizman B. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J. Gen. Virol. 1968, 2:357-364.
13. Field H.J., Clercq E.de Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment and maintenance of latent herpes simplex virus infection in mice. J. Gen. Virol. 1981, 56:259-265.
14. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985, 39:783-791.
15. Goel N., Mao H., Rong Q., Docherty J.J., Zimmerman D., Rosenthal K.S. The ability of an HSV strain to initiate zosteriform spread correlates with its neuroinvasive disease potential. Arch. Virol. 2002, 147:763-773.
16. Grose C. Korean War and the Origin of Herpes Simplex Virus 1 Strain KOS. J Virol. 2014, 88:1-2.
17. Haynes R.E., Azimi P.H., Cramblett H.G. Fatal herpesvirus hominis (herpes simplex virus) infections in children. Clinical, pathologic, and virologic characteristics. JAMA 1968, 206:312-319.
18. Hill T.J., Field H.J., Blyth W.A. Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. J. Gen. Virol. 1975, 28:341-353.
19. Heller M., Dix R.D., Baringer J.R., Schachter J., Conte J.E. Herpetic proctitis and meningitis: recovery of two strains of herpes simplex virus type 1 from cerebrospinal fluid. J. Infect. Dis. 1982, 146:584-588.
20. Holland T.C., Marlin S.D., Levine M., Glorioso J. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies. J. Virol. 1983, 45:672-682.
21. Howard P.W., Howard T.L., Johnson D.C. Herpes simplex virus membrane proteins gE/gI and US9 Act cooperatively to promote transport of capsids and glycoproteins from neuron cell bodies into initial axon segments. J. Virol. 2013, 87:403-414.
22. Johnston C., Koelle D.M., Wald A. HSV-2: in pursuit of a vaccine. J. Clin. Invest. 2011, 121:4600-4609.
23. Koyuncu O.O., Hogue I.B., Enquist L.W. Virus infections in the nervous system. Cell. Host Microbe 2013, 13:379-393.
24. Knipe D.M., Ruyechan W.T., Roizman B., Halliburtont I.A.N.W. Molecular genetics of herpes simplex virus: Demonstration of regions of obligatory and nonobligatory identity within diploid regions of the genome by sequence replacement and insertion. Proc. Natl. Acad. Sci. U.S.A. 1978, 75:3896-3900.
25. Kolb A.W., Ané C., Brandt C.R. Using HSV-1 genome phylogenetics to track past human migrations. Plos. One 2013, 8:1-9.
26. Kaur A., Sanford H.B., Garry D., Lang S., Klumpp S.A., Watanabe D., Bronson R.T., Lifson J.D., Rosati M., Pavlakis G.N., Felber B.K., Knipe D.M., Desrosiers R.C. Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus. Virology 2007, 357:199-214.
27. Katoh K., Misawa K., Kuma K., Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 2002, 30:3059-3066.
28. Little S.P., Schaffer P.A. Expression of the syncytial (syn) phenotype in HSV-1, strain KOS:genetic and phenotypic studies of mutants in two syn loci. Virology 1981, 112:686-702.
29. Lonsdale D.M., Brown S.M., Subak-Sharpe J.H., Warren K.G., Koprowski H. The polypeptide and the DNA restriction enzyme profiles of spontaneous isolates of herpes simplex virus type 1 from explants of human trigeminal, superior cervical and vagus ganglia. J. Gen. Virol. 1979, 43:151-171.
30. Liu X., Broberg E., Watanabe D., Dudek T., DeLuca N., Knipe D.M. Genetic engineering of a modified herpes simplex virus 1 vaccine vector. Vaccine 2009, 27:2760-2767.
31. Lyman M.G., Feierbach B., Curanovic D., Bisher M., Enquist L.W. Pseudorabies virus Us9 directs axonal sorting of viral capsids. J. Virol. 2007, 81:11363-11371.
32. Lyman M.G., Kemp C.D., Taylor M.P., Enquist L.W. Comparison of the pseudorabies virus Us9 protein with homologs from other veterinary and human alphaherpesviruses. J. Virol. 2009, 83:6978-6986.
33. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinform. Appl. Note 2007, 23:2947-2948.
34. Lole K.S., Bollinger R.C., Paranjape R.S., Gadkari D., Kulkarni S.S., Novak N.G., Ingersoll R., Sheppard H.W., Ray S.C. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 1999, 73:152-160.
35. Mettenleiter T.C., Klupp B.G., Granzow H. Herpesvirus assembly: an update. Virus Res. 2009, 143:222-234.
36. McGeoch D.J., Dolan A., Donald S., Street C. Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res. 1986, 14:1727-1746.
37. McGeoch D.J., Dalrymple M.A., Davison A.J., Dolan A., Frame M.C., McNab D., Perry L.J., Scott J.E., Taylor P. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 1988, 69:1531-1574.
38. Macdonald S.J., Mostafa H.H., Morrison L.A., Davido D.J. Genome sequence of herpes simplex virus 1 strain McKrae. J. Virol. 2012, 86:9540-9541.
39. Macdonald S.J., Mostafa H.H., Morrison L.A., Davido D.J. Genome sequence of herpes simplex virus 1 strain KOS. J. Virol. 2012, 86:6371-6372.
40. Mao H., Rosenthal K.S. An N-terminal arginine-rich cluster and a proline-alanine-threonine repeat region determine the cellular localization of the herpes simplex virus type 1 ICP34.5 protein and its ligand, protein phosphatase 1. J. Biol. Chem. 2002, 277:11423-11431.
41. Miles D.A. The role of ICP0 expression in reactivation of herpes simplex virus type 1 strains KOS-63 and KOS-79 (PhD dissertation) 2000, University of Arkansas at Little Rock, Arkansas, USA, Advisor: William Stroop.
42. McCarthy A.M., McMahan L., Schaffer P.A. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J. Virol. 1989, 63:18-27.
43. McGraw H.M., Awasthi S., Wojcechowskyj J.A., Friedman H.M. Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9. J. Virol. 2009, 83:8315-8326.
44. Negatsch A., Mettenleiter T.C., Fuchs W. Herpes simplex virus type 1 strain KOS carries a defective US9 and a mutated US8A gene. J. Gen. Virol. 2011, 92:167-172.
45. Norberg P., Tyler S., Severini A., Whitley R., Liljeqvist J.-A., Bergstrom T. A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. Plos One 2011, 6:1-8.
46. Norberg P., Kasubi M.J., Haarr L., Bergstrom T., Liljeqvist J.-A. Divergence and recombination of clinical herpes simplex virus type 2 isolates. J. Virol. 2007, 81:13158-13167.
47. Osorio Y., Cohen J., Ghiasi H. Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines. Investig. Opthalmol. Vis. Sci. 2004, 45:506.
48. Pellett P.E., Roizman B. Herpesviridae, In Fields Virology 2013, 1802-1822. Lippincott Williams & Wilkins, Philadelphia, PA. 6th ed.
49. Parsons L.R., Tafuri Y.R., Shreve J.T., Bowen C.D., Shipley M.M., Enquist L.W., Szpara M.L. Rapid genome assembly and comparison decode intrastrain variation in human alphaherpesviruses. mBio 2015, 6:e02213-e02214.
50. Payne K.M., Russell D.A., Kinchington P.R. Complete genome sequence of herpes simplex virus type-1 strain KOS. GenBank Access JQ780693.
51. Quinlivan M., Breuer J. Clinical and molecular aspects of the live attenuated Oka varicella vaccine: studies of the Oka varicella vaccine. Rev. Med. Virol. 2014, 24:254-273.
52. Roizman B., Knipe D.M., Whitley R. Herpes Simplex Viruses, In Fields Virology 2013, 1823-1897. Lippincott Williams & Wilkins, Philadelphia, PA. 6th ed.
53. Roizman B., Whitley R.J. An inquiry into the molecular basis of HSV latency and reactivation. Annu. Rev. Microbiol. 2013, 67:355-374.
54. Ramachandran S., Knickelbein J.E., Ferko C., Hendricks R.L., Kinchington P.R. Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters. Virology 2008, 378:254-264.
55. Smith K.O. Relationship between the envelope and the infectivity of herpes simplex virus. Exp. Biol. Med. 1964, 115:814-816.
56. Sedarati F., Stevens J.G. Biological basis for virulence of three strains of herpes simplex virus type 1. J. Gen. Virol. 1987, 68:2389-2395.
57. Stevens J.G. HSV-1 neuroinvasiveness. Intervirology 1993, 35:152-163.
58. Sato A., Linehan M.M., Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17343-17348.
59. Szpara M.L., Gatherer D., Ochoa A., Greenbaum B., Dolan A., Bowden R.J., Enquist L.W., Legendre M., Davison A.J. Evolution and diversity in human herpes simplex virus genomes. J. Virol. 2013, JVI.01987-13.
60. Skare J., Summers W.C. Structure and function of herpesvirus genomes: II. EcoRI, XbaI, and HindIII Endonuclease cleavage sites on Herpes Simplex Virus Type I DNA. Virology 1977, 76:581-595.
61. Sakaoka H., Aomori T., Saito H., Sato S., Kawana R., Hazlett D.T., Fujinaga K. A comparative analysis by restriction endonucleases of Herpes Simplex Virus type 1 isolated in Japan and Kenya. J. Infect. Dis. 1986, 153:612-616.
62. Snyder A., Polcicova K., Johnson D.C. Herpes simplex virus gE/gI and US9 proteins promote transport of both capsids and virion glycoproteins in neuronal axons. J. Virol. 2008, 82:10613-10624.
63. Spatz S.J. Accumulation of attenuating mutations in varying proportions within a high passage very virulent plus strain of Gallid herpesvirus type 2. Virus Res. 2010, 149:135-142.
64. Szpara M.L., Tafuri Y.R., Enquist L.W. Preparation of viral DNA from nucleocapsids. J. Vis. Exp. 2011, 2-7.
65. Strimmer K., Wiuf C., Moulton V. Recombination analysis using directed graphical models. Mol. Biol. Evol. 2001, 18:97-99.
66. Sneath P.H.A., Sokal R.R. Numerical Taxonomy 1973, W.H. Freeman and Company, San Francisco, California, USA.
67. Thiry E., Meurens F., Muylkens B., McVoy M., Gogev S., Thiry J., Vanderplasschen A., Epstein A., Keil G., Schynts F. Recombination in alphaherpesviruses. Rev. Med. Virol. 2005, 15:89-103.
68. Taylor M.P., Enquist L.W. Axonal spread of neuroinvasive viral infections. Trends Microbiol. 2015.
69. Tamura K., Stecher G., Peterson D., Filipski A., Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0. Mol. Biol. Evol. 2013, 30:2725-2729.
70. Whitley R.J., Soong S.J., Linneman C., Liu C., Pazin G., Alford C.A. Herpes simplex encephalitis. Clinical assessment. JAMA 1982, 247:317-320.
71. Whitley R.J., Soong S.J., Hirsch M.S., Karchmer A.W., Dolin R., Galasso G., Dunnick J.K., Alford C.A. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N. Engl. J. Med. 1981, 304:313-318.
72. Williams L.E., Nesburn A.B., Kaufman H.E. Experimental induction of disciform keratitis. Arch. Ophthalmol. 1965, 73:112-114.
73. Watson G., Xu W., Reed A., Babra B., Putman T., Wick E., Wechsler S.L., Rohrmann G.F., Jin L. Sequence and comparative analysis of the genome of HSV-1 strain McKrae. Virology 2012, 433:528-537.
74. Wang H., Davido D.J., Morrison L.A. HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice. Virus Res. 2013, 173:436-440.
75. Wilkie N.M., Cortini R., Clements J.B. Structural studies and physical maps for the herpes simplex virus genome. J. Antimicrob. Chemother. 1977, 3(A):47-62.
76. Zakirova N.F., Shipitsyn A.V., Jasko M.V., Prokofjeva M.M., Andronova V.L., Galegov G.A., Prassolov V.S., Kochetkov S.N. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro. Bioorg. Med. Chem. 2012, 20:5802-5809.